Fox Christine Ann

Chief Financial Officer at MREO

Sold, on record
$269k
Dollars the filings state
Form 4 sales
2
Latest Sep 13, 2024
Form 144 notices
2
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • MREOMereo BioPharma Group plcChief Financial Officer

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 144 notice MREONotice
    Jun 20, 2024 2024

    Filed to sell 46,672 shares ($186k)

    Fox Christine Ann, Officer

    No 10b5-1 planFirst sale on recordFiling

  2. 2 Form 4 sale MREOUnusual
    Jun 26, 2024 +6 days

    Sold 42,429 shares at $3.48 ($148k)

    Fox Christine Ann, Chief Financial Officer

    No 10b5-1 planSold 42.4% of holdings ($348k position)57,571 shares leftFirst sale on recordFollows a Form 144Filing

  3. 3 Form 144 notice MREONotice
    Sep 12, 2024 +78 days

    Filed to sell 28,286 shares ($132k)

    Fox Christine Ann, Officer

    No 10b5-1 planFiling

  4. 4 Form 4 sale MREONo plan
    Sep 13, 2024 +1 day

    Sold 28,286 shares at $4.30 ($122k)

    Fox Christine Ann, Chief Financial Officer

    No 10b5-1 planSold 24.1% of holdings ($506k position)89,285 shares leftFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Fox Christine Ann
Source
Sep 13, 2024Sep 16, 2024MREOChief Financial OfficerForm 4 sale28,286$122k24.1%No planSEC
Sep 12, 2024Sep 12, 2024MREOOfficerForm 144 notice28,286$132kNoticeSEC
Jun 26, 2024Jun 27, 2024MREOChief Financial OfficerForm 4 sale42,429$148k42.4%UnusualSEC
Jun 20, 2024Jun 20, 2024MREOOfficerForm 144 notice46,672$186kNoticeSEC